Limba
|
Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3.
Price | 1.262,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Iniparib (BSI-201, NSC-746045, IND-71677) is a PARP1inhibitor with demonstrated effectiveness in triple-negative breast cancer (TNBC). Phase 3. |